BIOLASE, INC. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 10 rows in 2023. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-06-08: Reporting owner Yale Kenneth P.; Form 4; Security Restricted Stock Unit; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2023-06-08: Reporting owner Somerman Martha J. DDS, PhD; Form 4; Security Restricted Stock Unit; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2023-06-08: Reporting owner ROPER JESS; Form 4; Security Restricted Stock Unit; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2023-06-08: Reporting owner OLoughlin Kathleen T; Form 4; Security Restricted Stock Unit; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-06-08 | Yale Kenneth P. Director | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +502,404 546,531 owned after | $0.00 | 2023-06-12 | |
| 2023-06-08 | Somerman Martha J. DDS, PhD Director | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +518,429 560,661 owned after | $0.00 | 2023-06-12 | |
| 2023-06-08 | ROPER JESS Director | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +512,821 554,596 owned after | $0.00 | 2023-06-12 | |
| 2023-06-08 | OLoughlin Kathleen T Director | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +502,404 543,331 owned after | $0.00 | 2023-06-12 | |
| 2023-06-08 | Summerhays Carol Gomez DDS Director | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +491,987 532,065 owned after | $0.00 | 2023-06-12 | |
| 2023-06-08 | LORD JONATHAN T MD Director | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +721,154 779,901 owned after | $0.00 | 2023-06-12 | |
| 2023-06-02 | Sandor Steven Officer (Chief Operating Officer) | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +58,000 87,265 owned after | $0.00 | 2023-06-06 | |
| 2023-06-02 | Bright Jennifer Officer (Chief Financial Officer) | 4/A | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +58,000 90,563 owned after | $0.00 | 2023-06-06 | |
| 2023-06-02 | Bright Jennifer Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +58,000 90,563 owned after | $0.00 | 2023-06-06 | |
| 2023-06-02 | BEAVER JOHN R Director, Officer (President & CEO) | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +486,255 688,162 owned after | $0.00 | 2023-06-06 |